Nosocomial outbreak of CTX-M-15-producing E. coli in Norway

APMIS

Volumn 115, Issue 2, 2007, Pages 120-126

  Naseer, Umaer ^a,b   Natås, Olav B ^c   Haldorsen, Bjørg C ^a,b   Bue, Berit ^c   Grundt, Heidi ^c   Walsh, Timothy R ^d   Sundsfjord, Arnfinn ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

CTX M 15; E. coli; Nosocomial; Outbreak

Indexed keywords

BACTERIAL ENZYME; CEFOTAXIMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; NITROFURANTOIN; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD SAMPLING; CLINICAL ARTICLE; EPIDEMIC; ESCHERICHIA COLI; FEMALE; GENE INSERTION SEQUENCE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; KIDNEY PARENCHYMA; LUNG PARENCHYMA; MALE; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX; PRIORITY JOURNAL; SPUTUM ANALYSIS; STRUCTURAL HOMOLOGY; URINARY TRACT;

BASE SEQUENCE; BETA-LACTAMASES; CROSS INFECTION; DNA PRIMERS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; NORWAY; PREVALENCE; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; URINARY TRACT INFECTIONS;

EID: 33846781795     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.apm_547.x     Document Type: Article

References (37)

1. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
2. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
3. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005;352:380-91.
4. Matsumoto Y, Ikeda F, Kamimura T, Yokota Y, Mine Y. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyiminocephalosporins. Antimicrob Agents Chemother 1988;32:1243-6.
5. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987;20:323-34.
6. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990;18:294-8.
7. Lahey. http://www.lahey.org/Studies/?D=http://www.lahey.org/studies/ webt.htm&C=404. 31-10-2005. Ref Type: Data File.
8. Bernard H, Tancrede C, Livrelli V, Morand A, Barthelemy M, Labia R. A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes. J Antimicrob Chemother 1992;29:590-2.
9. Gniadkowski M, Schneider I, Palucha A, Jungwirth R, Mikiewicz B, Bauernfeind A. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital inWarsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998;42:827-32.
10. Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001;201:237-41.
11. Sabate M, Tarrago R, Navarro F, Miro E, Verges C, Barbe J, et al. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 2000;44:1970-3.
12. Pai H, Choi EH, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 2001;39:3747-9.
13. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, Ould-Hocine Z, et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002;209:161-8.
14. Lartigue MF, Poirel L, Nordmann P. Diversity of genetic environment of bla(CTX-M) genes. FEMS Microbiol Lett 2004;234:201-7.
15. Chanawong A, M'Zali FH, Heritage J, Xiong JH, Hawkey PM. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002;46:630-7.
16. Poirel L, Lartigue MF, Decousser JW, Nordmann P. ISEcp1B-mediated transposition of blaCTXM in Escherichia coli. Antimicrob Agents Chemother 2005;49:447-50.
17. Gazouli M, Legakis NJ, Tzouvelekis LS. Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4. FEMS Microbiol Lett 1998;169:289-93.
18. Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold P, et al.A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 1992;20:158-63.
19. Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004;48:3758-64.
20. Leflon-Guibout V, Jurand C, Bonacorsi S, Espinasse F, Guelfi MC, Duportail F, et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004;48:3736-42.
21. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTXM extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004;54:735-43.
22. NORM/NORM-VET 2003. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. 2004.
23. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
24. Hansen DS, Sirot D, Kolmos HJ. [Extended spectrum beta-lactamases in Danish Klebsiella isolates]. Ugeskr Laeger 1998;160:2261-2.
25. Manninen R, Auvinen H, Huovinen P. Resistance to second- and third-generation cephalosporins among Escherichia coli and Klebsiella species is rare in Finland. Clin Microbiol Infect 1997;3:408-13.
26. Fang H, Lundberg C, Olsson-Liljequist B, Hedin G, Lindback E, Rosenberg A, et al. Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J Clin Microbiol 2004;42:5917-20.
27. Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTXM-15 extended-spectrum beta-lactamase (ESBL) in Poland. J Antimicrob Chemother 2002;50:393-6.
28. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003;12:3724-32.
29. Mushtaq S, Woodford N, Potz N, Livermore DM. Detection of CTX-M-15 extended-spectrum beta-lactamase in the United Kingdom. J Antimicrob Chemother 2003;52:528-9.
30. Lartigue MF, Poirel L, Nordmann P. First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob Agents Chemother 2004;48:4929-30.
31. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004;48:1249-55.
32. Markovska R, Schneider I, Keuleyan E, Bauernfeind A. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clin Microbiol Infect 2004;10:752-5.
33. Conceicao T, Brizio A, Duarte A, Lito LM, Cristino JM, Salgado MJ. First description of CTXM-15-producing Klebsiella pneumoniae in Portugal. Antimicrob Agents Chemother 2005;49:477-8.
34. Lartigue MF, Poirel L, Aubert D, Nordmann P. In vitro analysis of ISEcp1B-mediated mobilization of naturally occurring beta-lactamase gene blaCTX-M of Kluyvera ascorbata. Antimicrob Agents Chemother 2006;50:1282-6.
35. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991;173:697-703.
36. Sundsfjord A, Simonsen GS, Haldorsen B, Haaheim H, Hjekmevoll S, Littauer P, et al. Genetic methods for detection of antimicrobial resistance. APMIS 2004;112:815-37.
37. Munday CJ, Whitehead GM, Todd NJ, Campbell M, Hawkey PM. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J Antimicrob Chemother 2004;54:628-33.